By contrast, a study from the Brazilian population concluded that the COX-2 –1195G/A polymorphism was not associated with the risk for lung cancer (Moraes et al., 2017), which is in agreement with the results from our present study. This evidence concerns the gene PTGS2 and lung carcinoma.